Skip to main content

Animations

MJFF Publications

5681 - 5690 of 6255 Results
Title
Year
  • Year
  • 2021
  • 2024
  • 2017
  • 2013
  • 2013
  • 2015
  • 2016
  • 2021
  • 2025
  • 2011
  • Summary Details
    OPEN
    Title: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating Factors
    Journal Name: Journal of Patient-Centered Research and Reviews
    Publisher: Aurora Health Care, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.17294/2330-0698.1836
    Citation Count: 13
  • Summary Details
    OPEN
    Title: The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocol
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-024-03914-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000004609
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Money without collaboration won't bring cures
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm0213-127
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Parkinson's Disease Biomarkers: Resources for Discovery and Validation
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2013.246
    Citation Count: 6
  • Summary Details
    OPEN
    Title: The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results
    Journal Name: Journal of Translational Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12967-015-0704-9
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol
    Journal Name: JMIR Research Protocols
    Publisher: JMIR Publications Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2196/resprot.5990
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
    Journal Name: Physiology News
    Publisher: The Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.36866/pn.123.32
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Long read sequencing reveals transgene concatemerization and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes in mouse zygotes
    Journal Name: Frontiers in Genome Editing
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fgeed.2025.1582097
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2
    Citation Count: 316
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.